Evaluation of subcutaneous amoxicillin/clavulanic acid pharmacokinetics as an alternative to the intravenous route in older patients—the PhASAge Study
Journal of Antimicrobial Chemotherapy2025Vol. 81(1)
Citations Over TimeTop 10% of 2025 papers
Nicolas Grégoire, David Mbarga, Hélène Mirfendereski, Françoise Stanke‐Labesque, Dominique Breilh, E. Forestier, Tristan Ferry, Sylvain Goutelle, G. Gavazzi, Thomas Brunet, Marc Paccalin, Claire Roubaud‐Baudron, the Infectiology and Geriatrics InterGroup (SPILF-SFGG GInGer), Guillaume Albaret, Caroline Hyernart, Elise Thiel, E. Mériglier, Didier Brönnimann, Peggy Blanc, Emilie Clabé, Hélène Domergue, H. Chaussade, Marion Lartigau, Patricia Pavèse, Isabelle Pierre, Cyprien Arlaud, Marie Froidure, Marion Le Maréchal, Sabine Drevet, Louise Allan, Catherine Bioteau, Cécile Pouderoux, Paul Chabert, Sylvain Gaujard, B. de la Gastine, Armelle Leperre, Youri Chauleur, Giuseppina Lanfranchi, Sophie Schir, Thomas Brunet, Alexandre Gueremy, Alexie Bosch, Anne-Laure Destrem, Margaux Isnard
Abstract
The present study provides data supporting the use of SC administration of AMX/CLV in the older population.